Author： Tien Jean Ching-Yi Xu Jianming
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.11, 2012-11, pp. : 1085-1096
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. :
Access to resources
Recommend
The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets, Vol. 12, Iss. 6, 2011-06 ,pp. :
Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy
Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. :
The mu opioid receptor: A new target for cancer therapy?
Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. :